Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada

Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada

Isolating and characterizing emerging SARS-CoV-2 variants is key to understanding virus pathogenesis. In this study, we isolated samples of the SARS-CoV-2 R.1 lineage, categorized as a variant under monitoring by the World Health Organization, and evaluated their sensitivity to neutralizing antibod...

Full description

Bibliographic Details
Main Authors: Rajesh Abraham Jacob, Ali Zhang, Hannah O. Ajoge, Michael R. D'Agostino, Kuganya Nirmalarajah, Altynay Shigayeva, Wael L. Demian, Sheridan J.C. Baker, Hooman Derakhshani, Laura Rossi, Jalees A. Nasir, Emily M. Panousis, Ahmed N. Draia, Christie Vermeiren, Jodi Gilchrist, Nicole Smieja, David Bulir, Marek Smieja, Michael G. Surette, Andrew G. McArthur, Allison J. McGeer, Samira Mubareka, Arinjay Banerjee, Matthew S. Miller, Karen Mossman
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2023-07-01
Series:Emerging Infectious Diseases
Subjects:
COVID-19
SARS-CoV-2
coronavirus disease
severe acute respiratory syndrome coronavirus 2
viruses
respiratory infections
Online Access:https://wwwnc.cdc.gov/eid/article/29/7/23-0198_article

Similar Items

Similar Items